Please assess the completion status of the following clinical trial:

Trial Title: Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects who successfully completed Study A3921030~Exclusion Criteria:~* Subjects who are on the waiting list for a second kidney transplant or any non-renal organ transplants

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Treatment Arm 1 (Type: ACTIVE_COMPARATOR): Treatment Arm 1 will also receive standard of care medications
- Treatment Arm 2 (Type: EXPERIMENTAL): Treatment Arm 2 will also receive standard of care medications
- Treatment Arm 3 (Type: EXPERIMENTAL): Treatment Arm 3 will also receive standard of care medications

Based on this trial design, predict the completion outcome and termination type (if applicable).